Literature DB >> 7153340

Long-term clinical, microbiological, and immunological observations of a volunteer repeatedly infected with Chlamydia trachomatis.

L Hanna, E Jawetz, C R Dawson, P Thygeson.   

Abstract

A blind volunteer was inoculated in one eye with an isolate of Chlamydia trachomatis in 1961 and followed for 20 years. During this time, many observations were made of his clinical responses to the first inoculation and several subsequent inoculations with the same and other strains, chlamydial shedding, and antibody and cell-mediated immune responses. Evidence is presented that partial resistance to chlamydial eye infection developed during repeated infections and that antibodies, cell-mediated immune reactions, and specific antigen in conjunctival cells persisted for many years after the last infection. The antibody response was directed mainly against the original infecting immunotype, regardless of whether the response was restimulated by infection with the same immunotype or with other immunotypes. The lymphocyte stimulation response appeared to be species specific.

Entities:  

Mesh:

Year:  1982        PMID: 7153340      PMCID: PMC272499          DOI: 10.1128/jcm.16.5.895-900.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Chlamydial infection of neonates.

Authors:  E Jawetz; L Hanna
Journal:  J Infect Dis       Date:  1979-07       Impact factor: 5.226

2.  Antibodies to TRIC agents in matched human tears and sera.

Authors:  L Hanna; E Jawetz; O Briones; H B Ostler; H Keshishyan; C R Dawson
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

3.  Titration and typing of serum antibodies in TRIC infections by immunofluorescence.

Authors:  L Hanna; E Jawetz; B Nabli; I Hoshiwara; B Ostler; C Dawson
Journal:  J Immunol       Date:  1972-01       Impact factor: 5.422

4.  Type-specific antibodies in human Chlamydia trachomatis infections of the eye.

Authors:  O C Briones; L Hanna; E Jawetz; C R Dawson; H B Ostler
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

5.  Latency in human infections with TRIC agents.

Authors:  L Hanna; C R Dawson; O Briones; P Thygeson; E Jawetz
Journal:  J Immunol       Date:  1968-07       Impact factor: 5.422

6.  Experimental inclusion conjunctivitis in man: measurements of infectivity and resistance.

Authors:  E Jawetz; L Rose; L Hanna; P Thygeson
Journal:  JAMA       Date:  1965-11-08       Impact factor: 56.272

7.  Subclinical infections with TRIC agents.

Authors:  E Jawetz; L Hanna; C Dawson; R Wood; O Briones
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

8.  Infectivity for man of cell culture-adapted tric agents.

Authors:  L Hanna; C Dawson; E Jawetz
Journal:  Proc Soc Exp Biol Med       Date:  1967-11

9.  Human cell-mediated immune responses to chlamydial antigens.

Authors:  L Hanna; L Schmidt; M Sharp; D P Stites; E Jawetz
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

10.  Childhood trachoma in a nonendemic area. Danish trachoma patients and their close contacts, 1963 to 1973.

Authors:  C H Mordhorst; S P Wang; J T Grayston
Journal:  JAMA       Date:  1978-04-28       Impact factor: 56.272

View more
  3 in total

1.  Immune responses of mice after conjunctival exposure to Chlamydia trachomatis serovar A.

Authors:  I S Barsoum; L K Hardin; D G Colley
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

2.  A novel whole-bacterial enzyme linked-immunosorbant assay to quantify Chlamydia trachomatis specific antibodies reveals distinct differences between systemic and genital compartments.

Authors:  Hannah L Albritton; Pamela A Kozlowski; Rebecca A Lillis; Chris L McGowin; Julia D Siren; Stephanie N Taylor; Joyce A Ibana; Lyndsey R Buckner; Li Shen; Alison J Quayle
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

Review 3.  The global burden of trachoma: a review.

Authors:  Matthew J Burton; David C W Mabey
Journal:  PLoS Negl Trop Dis       Date:  2009-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.